T-Biovax

N/A

Report date: 2025/03/20 09:31:23

Base Information

Drug NameT-Biovax
Drug Alias Nametuberculosis vaccine (ImmunoBiology/Lanzhou Institute of Biological Product)HspC TBtuberculosis vaccine (ImmBio/Aeras)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHeat-shock protein modulators
TargetsHeat-shock protein
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesImmunobiology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAerasImmunobiology LtdLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A